N5: Unraveling Stress Levels Among Remote and In-Office Workers
Wed, 5/21: 1:00 PM - 2:00 PM CDT
00562
Education Session
00562
Education Session
Kansas City Convention Center
Room: 2502 A
CM Credit Hours: 1
Description
This presentation provides an update on past discussions of salivary cortisol biomarkers for stress measurement among remote and in-office workers. Salivary cortisol is a gold standard for quantitative measurement, correlating directly to stress. However, cortisol levels are susceptible to external factors, and responses are often delayed approximately 20 minutes. Salivary alpha-amylase, which reflects sympathetic activation, responds within 5–10 minutes. This makes alpha-amylase a valuable stress biomarker for cortisol analyses. We have integrated alpha-amylase into a dataset, allowing for a multidimensional approach by analyzing both biomarkers within the same study population. This session will: a) review key insights; b) provide updated analyses from past studies with a comparison of the results; c) present the results by remote work and in office settings, among other demographics; d) explain alpha-amylase's role and advantages in stress research; and e) discuss the biomarkers for future stress response measurements.
Learning Outcomes
Upon completion, the participant will be able to:
• Compare stressor-related markers, both enzymes and hormones.
• Describe the factors that affect worker well-being and productivity.
• Assess stress in remote versus office employees.
• Use biomarkers to determine stress levels.
• Determine how biomarkers serve as quantifiable stress indicators.
• Identify diagnostic biomarkers for chronic and acute stress.
• Examine when exposures can lead to the secretion of biomarkers.
• Manage the ethical considerations regarding the collection of biomarker data.
• Utilize biomarkers as an indicator of remote worker well-being.
• Apply Total Worker Health® programs to remote worker populations.
• Compare stressor-related markers, both enzymes and hormones.
• Describe the factors that affect worker well-being and productivity.
• Assess stress in remote versus office employees.
• Use biomarkers to determine stress levels.
• Determine how biomarkers serve as quantifiable stress indicators.
• Identify diagnostic biomarkers for chronic and acute stress.
• Examine when exposures can lead to the secretion of biomarkers.
• Manage the ethical considerations regarding the collection of biomarker data.
• Utilize biomarkers as an indicator of remote worker well-being.
• Apply Total Worker Health® programs to remote worker populations.
Content Level
Intermediate
Interactive Session Experience
Polling
Q&A
Organizational Category
Corporation/Company
Primary Industry
All Industries
Office Environment
Services
Topics
Also part of the Virtual Program
Available as part of AIHA Connect OnDemand
Changing Work Dynamics
Sampling and Analysis
Total Worker Health®